Concepedia

Publication | Closed Access

Idarucizumab for Dabigatran Reversal

DOI

1.4K

Citations

9

References

2015

Year

Charles V. Pollack, Paul A. Reilly, John W. Eikelboom, Stephan Glund, Peter Verhamme, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jerrold H. Levy,
New England Journal of Medicine

Abstract

Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.).

References

YearCitations

Page 1